Skin & AestheticsOTC CosmeticB

SNAP-8

Acetyl Octapeptide-3

Topical cosmetic peptide used in anti-wrinkle formulations.

Last reviewed . First published . By the PeptIQ team.

Observational report only — live community data. Not medical advice. Does not recommend doses, protocols, or treatments.
Studies cited
4
Research grade
B
Experience
55

Overall check-ins

Activity
71

Trackers & reports

Overview

About SNAP-8

Topical cosmetic peptide used in anti-wrinkle formulations.

Category
Skin & Aesthetics
Regulatory status
OTC Cosmetic
Also known as
Acetyl Octapeptide-3
Self-reports
6

Community

What 6 users report

6 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 0% · Mixed 100% · Unfavorable overall 0%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Energy
6
Mood
6

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Injection site irritation
6

Self-reported dose per injection

Median bucket: 0–25 mcg · Most common: 0–25 mcg

Reports cluster around 0–25 mcg

0–25
6

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

Commonly stacked with

Research

Sources (3)

  1. PubMed

    Acetyl hexapeptide-3 in a emulsion formulation for reduced wrinkle depth

    Raikou V, Varvaresou A, Panderi I, et al. J Cosmet Dermatol. 2009

    Source
    Wiki study page →
  2. PubMed

    Targeting lymphoid-derived IL-17 signaling to delay skin aging

    Solá P, Mereu E, Bonjoch J, et al. Nature aging. 2023

    Source
    Wiki study page →
  3. PubMed

    Myofibroblast proliferation and heterogeneity are supported by macrophages during skin repair

    Shook BA, Wasko RR, Rivera-Gonzalez GC, et al. Science (New York, N.Y.). 2018

    Source
    Wiki study page →

Tools

Explore more

Explore

More ways to learn about SNAP-8 from observational PeptIQ data.

Related peptides

Help

Frequently asked

What do PeptIQ users report about SNAP-8?

This page summarizes 6 anonymized self-reports from PeptIQ users who track SNAP-8, including commonly reported effects and co-tracked peptides. These are observational patterns, not clinical outcomes.

How do side effects relate to overall experience for SNAP-8?

PeptIQ separates overall check-in ratings (favorable, mixed, or unfavorable) from logged side effects like nausea or fatigue. Users often report benefits and side effects in the same check-in — a high experience score does not mean zero side effects were noted.

What research is cited for SNAP-8?

3 sources are linked on this page, including PubMed articles, clinical trial registries, and FDA labels where applicable. Citations describe published research — not recommendations.

Is SNAP-8 safe to use?

This wiki does not assess safety or recommend use. SNAP-8 is listed as OTC Cosmetic. Consult a licensed clinician for personal medical decisions.

What are the purported benefits and uses of SNAP-8?

This wiki summarizes observational community reports and linked citations for SNAP-8. It does not assert therapeutic benefits. See the sources list on this page and the educational profile for SNAP-8 for study-level context — not medical advice.

What is the legal status of SNAP-8?

SNAP-8 is listed in PeptIQ as OTC Cosmetic. Regulatory status varies by jurisdiction and can change. This wiki does not provide legal advice; check current FDA and local rules and talk with a licensed clinician or counsel for personal decisions.

What are the known or theoretical side effects and risks of SNAP-8?

Safety data quality for SNAP-8 varies widely by compound and study design. PeptIQ does not establish a risk profile here. Review primary literature, product labeling where applicable, and clinician guidance. Community self-reports are not a substitute for clinical evidence.

What is the current state of research on SNAP-8?

This page links 3 sources for SNAP-8. Evidence maturity differs by application — some peptides have large human programs, others are mostly preclinical. Treat citation counts as literature volume, not proof of efficacy.